Skip to main content
SpringerLink
Log in

Antipyrine kinetics in undernourished diabetics

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In developing countries diabetics frequently suffer from varying grades of malnutrition. The combined effect of malnutrition and non-insulin dependent diabetes (NIDDM) on the drug metabolising enzyme system has been evaluated using antipyrine as a protodrug. All the patients were under treatment and their plasma glucose values were within normal limits.

The AUC of antipyrine was similar in all the groups. Although none of the kinetic parameters was altered in normal diabetics, the clearance of antipyrine was decreased and its half life was prolonged, with an increase in volume of distribution, in undernourished diabetics compared to undernourished controls. The results indicate that diabetes per se may not influence antipyrine kinetics when the blood glucose is well under control, but in the presence of undernutrition, it significantly alters the disposition of the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organisation (1985) Diabetes mellitus WHO Technical Report Series No 727, WHO, Geneva

    Google Scholar 

  2. Pasi I, Salmela, Eero A, Sotaniemi EA, Pelkonen RO (1980) The evaluation of the drug metabolising capacity in patients with diabetes mellitus. Diabetes 29: 788–794

    Google Scholar 

  3. Pirttiaho HI, Salmela PI, Sotaniemi EA, Pelkonen RO, Pitkanen U, Luoma PV (1984) Drug metabolism in diabetic subjects with fatty livers. Br J Clin Pharmacol 18: 895–899

    Google Scholar 

  4. Daintith H, Stevenson IH, O'Malley KO (1976) Influence of diabetes mellitus on drug metabolism in man. Int J Clin Pharmacol 13: 55–58

    Google Scholar 

  5. Zysset T, Wietholtz H (1988) Differential effect of Type I and Type II diabetes on antipyrine disposition in man. Eur J Clin Pharmacol 34: 369–375

    Google Scholar 

  6. Murali KV, Adithan C, Sashindharan CH, Gambhir SS, Chandrasekhar S (1983) Antipyrine metabolism in patients with diabetes mellitus. Clin Exp Pharmacol Physiol 10: 7–13

    Google Scholar 

  7. Krishnaswamy K (1978) Drug metabolism and pharmacokinetics in malnutrition. Clin Pharmacokinet 3: 216–240

    Google Scholar 

  8. Rao KSJ, Mukherjee NR, Rao KV (1972) A survey of diabetes mellitus in a rural population of India. Diabetes 21: 1192–1196

    Google Scholar 

  9. Shargel L, Cheng W, Yu ABC (1979) High pressure liquid chromatographic analysis of antipyrine in small plasma samples. J Pharm Sci 68: 1052–1053

    Google Scholar 

  10. Zysset T, Sommer L (1986) Diabetes alters drug metabolism in vivo studies in a streptozotozin — diabetic rat model. Experientia 42: 560–562

    Google Scholar 

  11. Past MR, Cook DE (1982) Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes dependent rat liver cytochrome P-450. Biochem Pharmacol 31: 3329–3334

    Google Scholar 

  12. Anderson KE (1988) Influence of diet and nutrition on clinical pharmacokinetics. Clin Pharmacokinet 14: 325–346

    Google Scholar 

  13. Campbell TC, Hayes JR (1974) Role of nutrition in the drug metabolising enzyme system. Pharmacol Rev 26: 171–197

    Google Scholar 

  14. Vesell ES (1979) The antipyrine test in clinical pharmacology: Conceptions and misconceptions. Clin Pharmacol Ther 26: 275–286

    Google Scholar 

  15. Sultatos LG, Dvorchik BH, Vesell ES, Shand DG, Branch RA (1980) Further observations on relationships between antipyrine half life, clearance and volume of distribution: An appraisal of alternative kinetic parameters used to assess the elimination of antipyrine. Clin Pharmacokinet 5: 263–273

    Google Scholar 

  16. Krishnaswamy K, Naidu AN (1977) Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine. Br Med J 1: 538–540

    Google Scholar 

  17. Narang APS, Dutta DV, Khare AK (1987) Impairment of drug clearance in patients with diabetes mellitus and liver cirrhosis. Ind J Med Res 85: 321–325

    Google Scholar 

  18. Vestal RE, Norris AH, Tobin JD, Cohen BJH, Shock NW, Andres R (1975) Antipyrine metabolism in man: Influence of age, alcohol, caffeine and smoking. Clin Pharmacol Ther 18: 425–432

    Google Scholar 

  19. Branch RA, James JA, Read AE (1976) The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease. Clin Pharmacol Ther 20: 81–89

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology Gandhi Medical College, India

    J. C. Shobha & A. Deva Kumar

  2. National Institute of Nutrition Indian Council of Medical Research Jamai-Osmania, Hyderabad, India

    T. C. Raghuram & K. Krishnaswamy

Authors
  1. J. C. Shobha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. C. Raghuram
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Deva Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Krishnaswamy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shobha, J.C., Raghuram, T.C., Kumar, A.D. et al. Antipyrine kinetics in undernourished diabetics. Eur J Clin Pharmacol 41, 359–361 (1991). https://doi.org/10.1007/BF00314968

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314968

Key words

Search

Navigation